Literature DB >> 26338782

What Medicare Is Missing.

Sara Keller1, Peter Pronovost2, Sara Cosgrove3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26338782      PMCID： PMC4657539          DOI： 10.1093/cid/civ750

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Financial impact of a home intravenous antibiotic program on a medicare managed care program.

Authors:  J R Dalovisio; J Juneau; K Baumgarten; J Kateiva
Journal:  Clin Infect Dis       Date:  2000-04-04       Impact factor: 9.079

2.  Outpatient intravenous medications in the management of cystic fibrosis.

Authors:  R W Rucker; G M Harrison
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

Review 3.  Outpatient parenteral antimicrobial therapy today.

Authors:  Joseph A Paladino; Donald Poretz
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079
  3 in total
  7 in total

1.  A new frontier: Central line-associated bloodstream infection surveillance in home infusion therapy.

Authors:  Sara C Keller; Deborah Williams; Clare Rock; Shiv Deol; Polly Trexler; Sara E Cosgrove
Journal:  Am J Infect Control       Date:  2018-06-13       Impact factor: 2.918

2.  Environmental Exposures and the Risk of Central Venous Catheter Complications and Readmissions in Home Infusion Therapy Patients.

Authors:  Sara C Keller; Deborah Williams; Mitra Gavgani; David Hirsch; John Adamovich; Dawn Hohl; Amanda Krosche; Sara Cosgrove; Trish M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2016-10-04       Impact factor: 3.254

3.  Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy.

Authors:  Sara C Keller; Deborah Williams; Mitra Gavgani; David Hirsch; John Adamovich; Dawn Hohl; Ayse P Gurses; Sara E Cosgrove
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

4.  Changes in Infective Endocarditis Admissions in Pennsylvania During the Opioid Epidemic.

Authors:  Jessica A Meisner; Judith Anesi; Xinwei Chen; David Grande
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 20.999

5.  COVID-19 and Outpatient Parenteral Antimicrobial Therapy: The Need to Protect Vulnerable Medicare Beneficiaries.

Authors:  Yasir Hamad; Karen E Joynt Maddox; William G Powderly
Journal:  Ann Intern Med       Date:  2020-05-13       Impact factor: 25.391

6.  Which Patients Discharged to Home-Based Outpatient Parenteral Antimicrobial Therapy Are at High Risk of Adverse Outcomes?

Authors:  Sara C Keller; Nae-Yuh Wang; Alejandra Salinas; Deborah Williams; Jennifer Townsend; Sara E Cosgrove
Journal:  Open Forum Infect Dis       Date:  2020-05-20       Impact factor: 3.835

7.  Patient Experiences With Outpatient Parenteral Antibiotic Therapy: Results of a Patient Survey Comparing Skilled Nursing Facilities and Home Infusion.

Authors:  Omar Mansour; Alicia I Arbaje; Jennifer L Townsend
Journal:  Open Forum Infect Dis       Date:  2019-11-04       Impact factor: 3.835
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.